Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Financial Companies: Marsh & McLennan Companies (MRSH) and CME Group (CME)

Tipranks - Tipranks - Fri Apr 17, 11:36PM CDT

Analysts fell to the sidelines weighing in on Marsh & McLennan Companies (MRSH) and CME Group (CME) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Claim 30% Off TipRanks

Marsh & McLennan Companies (MRSH)

In a report released today, Harry Fong from Roth MKM maintained a Hold rating on Marsh & McLennan Companies, with a price target of $200.00. The company’s shares closed last Thursday at $182.57.

According to TipRanks.com, Fong is a 5-star analyst with an average return of 10.4% and a 66.2% success rate. Fong covers the Financial sector, focusing on stocks such as Octave Specialty Group, Willis Towers Watson, and Cincinnati Financial. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Marsh & McLennan Companies with a $203.19 average price target, implying a 14.0% upside from current levels. In a report released yesterday, TipRanks – Google also downgraded the stock to Hold with a $191.00 price target.

See today’s best-performing stocks on TipRanks >>

CME Group (CME)

In a report issued on April 15, Ashish Sabadra from RBC Capital maintained a Hold rating on CME Group, with a price target of $302.00. The company’s shares closed last Thursday at $296.22.

According to TipRanks.com, Sabadra is a 4-star analyst with an average return of 2.7% and a 53.9% success rate. Sabadra covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Cboe Global Markets, and Factset Research. ;'>

CME Group has an analyst consensus of Hold, with a price target consensus of $306.40, which is a 3.5% upside from current levels. In a report issued on April 8, KBW also resumed coverage with a Hold rating on the stock with a $305.00 price target.

Read More on MRSH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).